IRIS Accounts Production v24.3.0.553 09604314 director 1.6.23 31.7.24 31.7.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh096043142023-05-31096043142024-07-31096043142023-06-012024-07-31096043142022-05-31096043142022-06-012023-05-31096043142023-05-3109604314ns15:EnglandWales2023-06-012024-07-3109604314ns14:PoundSterling2023-06-012024-07-3109604314ns10:Director12023-06-012024-07-3109604314ns10:PrivateLimitedCompanyLtd2023-06-012024-07-3109604314ns10:SmallEntities2023-06-012024-07-3109604314ns10:AuditExempt-NoAccountantsReport2023-06-012024-07-3109604314ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-07-3109604314ns10:SmallCompaniesRegimeForAccounts2023-06-012024-07-3109604314ns10:FullAccounts2023-06-012024-07-3109604314ns10:RegisteredOffice2023-06-012024-07-3109604314ns5:CurrentFinancialInstruments2024-07-3109604314ns5:CurrentFinancialInstruments2023-05-3109604314ns5:ShareCapital2024-07-3109604314ns5:ShareCapital2023-05-3109604314ns5:RetainedEarningsAccumulatedLosses2024-07-3109604314ns5:RetainedEarningsAccumulatedLosses2023-05-3109604314ns5:PlantMachinery2023-06-012024-07-3109604314ns5:PlantMachinery2023-05-3109604314ns5:PlantMachinery2024-07-3109604314ns5:PlantMachinery2023-05-3109604314ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3109604314ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-31096043141ns10:Director12023-05-31096043141ns10:Director12022-05-31096043141ns10:Director12023-06-012024-07-31096043141ns10:Director12022-06-012023-05-31096043141ns10:Director12024-07-31096043141ns10:Director12023-05-310960431412023-06-012024-07-31
REGISTERED NUMBER: 09604314 (England and Wales)






















Unaudited Financial Statements

for the Period 1 June 2023 to 31 July 2024

for

McVean Medical Limited

McVean Medical Limited (Registered number: 09604314)






Contents of the Financial Statements
for the period 1 June 2023 to 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


McVean Medical Limited

Company Information
for the period 1 June 2023 to 31 July 2024







DIRECTOR: Dr E F Cameron





REGISTERED OFFICE: Suite 1, First Floor
Coachworks Arcade
Northgate Street
Chester
Cheshire
CH1 2EY





REGISTERED NUMBER: 09604314 (England and Wales)





ACCOUNTANTS: Bennett Brooks & Co Ltd
Chartered Accountants
Suite 1, First Floor
Coachworks Arcade
Northgate Street
Chester
Cheshire
CH1 2EY

McVean Medical Limited (Registered number: 09604314)

Balance Sheet
31 July 2024

2024 2023
Notes £ £
FIXED ASSETS
Tangible assets 4 4,878 3,948

CURRENT ASSETS
Debtors 5 107,816 115,452
Cash at bank 59,520 57,305
167,336 172,757
CREDITORS
Amounts falling due within one year 6 (6,449 ) (10,267 )
NET CURRENT ASSETS 160,887 162,490
TOTAL ASSETS LESS CURRENT
LIABILITIES

165,765

166,438

PROVISIONS FOR LIABILITIES (978 ) (750 )
NET ASSETS 164,787 165,688

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 164,777 165,678
SHAREHOLDERS' FUNDS 164,787 165,688

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 October 2024 and were signed by:





Dr E F Cameron - Director


McVean Medical Limited (Registered number: 09604314)

Notes to the Financial Statements
for the period 1 June 2023 to 31 July 2024

1. STATUTORY INFORMATION

McVean Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net sales of services provided in the period, which are exempt from value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2023 - 2 ) .

McVean Medical Limited (Registered number: 09604314)

Notes to the Financial Statements - continued
for the period 1 June 2023 to 31 July 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1 June 2023 7,076
Additions 2,702
Disposals (443 )
At 31 July 2024 9,335
DEPRECIATION
At 1 June 2023 3,128
Charge for period 1,468
Eliminated on disposal (139 )
At 31 July 2024 4,457
NET BOOK VALUE
At 31 July 2024 4,878
At 31 May 2023 3,948

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade debtors 5,775 4,450
Other debtors 102,041 111,002
107,816 115,452

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade creditors 433 334
Taxation and social security 4,667 7,955
Other creditors 1,349 1,978
6,449 10,267

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 July 2024 and the year ended 31 May 2023:

2024 2023
£ £
Dr E F Cameron
Balance outstanding at start of period 87,256 93,704
Amounts advanced 26,700 27,515
Amounts repaid (35,661 ) (33,963 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period 78,295 87,256

McVean Medical Limited (Registered number: 09604314)

Notes to the Financial Statements - continued
for the period 1 June 2023 to 31 July 2024

8. RELATED PARTY DISCLOSURES

Included within other debtors is an amount of £78,295 (2023 £87,256 ) owed to the company from Dr E F Cameron, the director of the company. No interest is charged on this balance. It is unsecured and repayable on demand.

9. ULTIMATE CONTROLLING PARTY

During the year the company was controlled by Dr E F Cameron, the director of the company, and his wife Dr G Cameron by virtue of them owning the entire ordinary share capital.